Physician profile
Douglas Scott
NPI 1043545965
$506.00
in general payments reported to CMS, 2019-2025
8 companies · $35.18 in 2025
The $35.18 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $43.25 · 2021: $33.33 · 2022: $48.54 · 2023: $18.57 · 2024: $327 · 2025: $35.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $305 · Food and Beverage: $75.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $305.33 |
| Food and Beverage | $75.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $305.33 | 2024 | Combogesic IV |
| Peerless Surgical INC. | $48.54 | 2022 | |
| Abbott Laboratories | $42.46 | 2020-2023 | Proclaim |
| Pacira Therapeutics, INC. | $38.84 | 2020-2021 | |
| Heron Therapeutics, INC. | $21.80 | 2024 | Zynrelef |
| Curonix LLC | $20.44 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Innovation Technologies INC | $14.74 | 2025 | Irrisept |
| Pfizer INC. | $13.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.